贝洛特罗:我们现在所知道的

Chelsea Shope, Laura Andrews, Alan Snyder, Todd Schlesinger
{"title":"贝洛特罗:我们现在所知道的","authors":"Chelsea Shope,&nbsp;Laura Andrews,&nbsp;Alan Snyder,&nbsp;Todd Schlesinger","doi":"10.1002/der2.180","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Belotero® Balance is a monophasic, polydensified hyaluronic acid gel filler (HAF) with a cross-linked with 1,4-butanediol diglycidyl ether. Belotero uses a unique, two-step cross-linking process yielding a highly cross-linked, cohesive gel with characteristic soft, smooth, flowing quality. Belotero is the only monophasic, polydensified gel currently approved by the FDA. It is highly efficacious for correction of very fine lines. Belotero Balance is formulated free from lidocaine, and thus should be avoided for injections in nerve-dense areas. Like other HAFs, the side effect profile of Belotero is minimal, and the product is temporary and reversible with hyaluronidase.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>In this chapter we discuss Belotero's FDA approval, uses and indications, efficacy as compared to other HAFs, and adverse effects, as well as new products on the horizon.</p>\n </section>\n </div>","PeriodicalId":100366,"journal":{"name":"Dermatological Reviews","volume":"4 2","pages":"96-99"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Belotero: What we know now\",\"authors\":\"Chelsea Shope,&nbsp;Laura Andrews,&nbsp;Alan Snyder,&nbsp;Todd Schlesinger\",\"doi\":\"10.1002/der2.180\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Belotero® Balance is a monophasic, polydensified hyaluronic acid gel filler (HAF) with a cross-linked with 1,4-butanediol diglycidyl ether. Belotero uses a unique, two-step cross-linking process yielding a highly cross-linked, cohesive gel with characteristic soft, smooth, flowing quality. Belotero is the only monophasic, polydensified gel currently approved by the FDA. It is highly efficacious for correction of very fine lines. Belotero Balance is formulated free from lidocaine, and thus should be avoided for injections in nerve-dense areas. Like other HAFs, the side effect profile of Belotero is minimal, and the product is temporary and reversible with hyaluronidase.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>In this chapter we discuss Belotero's FDA approval, uses and indications, efficacy as compared to other HAFs, and adverse effects, as well as new products on the horizon.</p>\\n </section>\\n </div>\",\"PeriodicalId\":100366,\"journal\":{\"name\":\"Dermatological Reviews\",\"volume\":\"4 2\",\"pages\":\"96-99\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Dermatological Reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/der2.180\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatological Reviews","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/der2.180","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景Belotero®Balance是一种单相、多增敏透明质酸凝胶填料(HAF),与1,4-丁二醇二缩水甘油醚交联。Belotero采用独特的两步交联工艺,生产出具有柔软、光滑、流动特性的高度交联、粘性凝胶。Belotero是目前唯一获得美国食品药品监督管理局批准的单相多增敏凝胶。它对非常细的线条的矫正非常有效。Belotero Balance的配方不含利多卡因,因此应避免在神经密集区域注射。与其他HAF一样,Belotero的副作用很小,并且该产品是暂时的,使用透明质酸酶是可逆的。结论在本章中,我们讨论了Belotero的FDA批准、用途和适应症、与其他HAF相比的疗效、不良反应以及即将推出的新产品。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Belotero: What we know now

Background

Belotero® Balance is a monophasic, polydensified hyaluronic acid gel filler (HAF) with a cross-linked with 1,4-butanediol diglycidyl ether. Belotero uses a unique, two-step cross-linking process yielding a highly cross-linked, cohesive gel with characteristic soft, smooth, flowing quality. Belotero is the only monophasic, polydensified gel currently approved by the FDA. It is highly efficacious for correction of very fine lines. Belotero Balance is formulated free from lidocaine, and thus should be avoided for injections in nerve-dense areas. Like other HAFs, the side effect profile of Belotero is minimal, and the product is temporary and reversible with hyaluronidase.

Conclusion

In this chapter we discuss Belotero's FDA approval, uses and indications, efficacy as compared to other HAFs, and adverse effects, as well as new products on the horizon.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信